Pathophysiology of human genetic CD36 deficiency

Trends in Cardiovascular Medicine

Volumn 13, Issue 4, 2003, Pages 136-141

  Hirano, Ken Ichi ^a,b   Kuwasako, Takahiro ^a   Nakagawa Toyama, Yumiko ^a   Janabi, Mohamed ^a   Yamashita, Shizuya ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANION; CARRIER PROTEIN; CD36 ANTIGEN; COLLAGEN; CYTOKINE; HEXARELIN; INSULIN; INTERLEUKIN 1BETA; LIGAND; LONG CHAIN FATTY ACID; MEMBRANE PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; SCAVENGER RECEPTOR; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA;

AFRICA; ANTIGEN EXPRESSION; APOPTOSIS; ASIAN; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ERYTHROCYTE; FATTY ACID TRANSPORT; FOAM CELL; GENE MUTATION; GENETIC DISORDER; HEART; HUMAN; IN VITRO STUDY; INCIDENCE; INFLAMMATION; INSULIN RESISTANCE; MALARIA; METABOLIC DISORDER; MOLECULAR BIOLOGY; MOLECULAR WEIGHT; MONOCYTE; NONHUMAN; NULL ALLELE; PATHOGENICITY; PATHOPHYSIOLOGY; PHENOTYPE; PHOTORECEPTOR; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; THROMBOCYTE; TISSUE DISTRIBUTION;

ANIMALS; ANTIGENS, CD36; CARDIOVASCULAR DISEASES; HUMANS; MYOCYTES, CARDIAC;

EID: 0038640337     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(03)00026-4     Document Type: Review

References (60)

1. Abumrad N.A., el-Maghrabi M.R., Amri E.Z.et al. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD. 36.(J Biol Chem 268):1993;17,665-17,668.
2. Aitman T.J., Cooper L.D., Norsworthy P.J.et al. Malaria susceptibility and CD36 mutation. Nature. 405:2000;1015-1016.
3. Aitman T.J., Glazier A.M., Wallace C.A.et al. Identification of CD36 (fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet. 21:1999;76-83.
4. Alessio M., De Monte L., Scirea A.et al. Synthesis, processing, and intracellular transport of CD36 during monocytic differentiation. J Biol Chem. 271:1996;1770-1775.
5. Bodart V., Febbraio M., Demers A.et al. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res. 90:2002;844-849.
6. Brown M.S., Goldstein J.L. Lipoprotein metabolism in the macrophages. implications for cholesterol deposition in atherosclerosis Ann Rev Biochem. 52:1983;222-261.
7. Collart M.A., Baeuerie P., Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages. involvement of four kappa B-like motifs and of constitutive and inducible forms of NK-kappa B Mol Cell Biol. 10:1990;1498-1506.
8. Curtis B.R., Aster R.H. Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians. Transfusion. 36:1996;331-334.
9. Dawson D.W., Pearce S.F., Zhong R.et al. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol. 138:1997;707-717.
10. Endemann G., Stanton L.W., Madden K.S.et al. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 268:1993;11,811-11,816.
11. Febbraio M., Abumrad N.A., Hajjar D.P.et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem. 274:1999;19,055-19,062.
12. Febbraio M., Hajjar D.P., Silverstein R.L. CD36. a class b scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism J Clin Invest. 108:2001;785-791.
13. Febbraio M., Podrez E.A., Smith J.D.et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest. 105:2000;1049-1056.
14. Finnemann S.C., Silverstein R.L. Differential roles of CD36 and αβ integrin in photoreceptor phagocytosis by the retinal pigment epithelium. J Exp Med. 194:2001;1289-1298.
15. Glazier A.M., Scott J., Aitman T.J. Molecular basis of the CD36 chromosomal deletion underlying SHR defects in insulin action and fatty acid metabolism. Mamm Genome. 13:2002;108-113.
16. Gotoda T., Iizuka Y., Kato N.et al. Absence of CD36 mutation in the original spontaneously hypertensive rats with insulin resistance. Nat Genet. 22:1999;226-228.
17. Greenwalt D.E., Scheck S.H., Rhinehart-Jones T. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J Clin Invest. 96:1995;1382-1388.
18. Griffin E., Re A., Hamel N.et al. A link between diabetes and atherosclerosis. glucose regulates expression of CD36 at the level of translation Nat Med. 7:2001;840-846.
19. Hajri T., Han X.X., Bonen A., Abumrad N.A. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest. 109:2002;1381-1389.
20. Hajri T., Ibrahimi A., Coburn C.T.et al. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J Biol Chem. 276:2001;23,661-23,666.
21. Hirano K., Kuwasako T., Kashiwagi H.et al. Insulin resistance and CD36 deficiency. Lancet. 358:2001;244.
22. Huh H.Y., Pearce S.F., Yesner L.M.et al. Regulated expression of CD36 during monocyte-to-macrophage differentiation. potential role of CD36 in foam cell formation Blood. 87:1996;2020-2028.
23. Ikeda H., Mitani T., Ohnuma M.et al. A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang. 57:1989;213-217.
24. Janabi M., Yamashita S., Hirano K.et al. Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler Thromb Vasc Biol. 20:2000;1953-1960.
25. Janabi M., Yamashita S., Hirano K.et al. Reduced adhesion of monocyte-derived macrophages from CD36-deficient patients to type I collagen. Biochem Biophys Res Commun. 283:2001;26-30.
26. Jimenez B., Volpert O.V., Crawford S.E.et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med. 6:2000;41-48.
27. Kashiwagi H., Honda S., Tomiyama Y.et al. A novel polymorphism in glycoprotein IV (replacement of proline-90 by serine) predominates in subjects with platelet GPIV deficiency. Thromb Haemost. 69:1993;481-484.
28. Kashiwagi H., Tomiyama Y., Kosugi S.et al. Identification of molecular defects in a subject with type I CD36 deficiency. Blood. 83:1994;3545-3552.
29. Kashiwagi H., Tomiyama Y., Kosugi S.et al. Family studies of type II CD36 deficient subjects. linkage of a CD36 allele to a platelet-specific mRNA expression defect(s) causing type II CD36 deficiency Thromb Haemost. 74:1995;758-763.
30. Kashiwagi H., Tomiyama Y., Nozaki S.et al. Analyses of genetic abnormalities in type I CD36 deficiency in Japan. identification and cell biological characterization of two novel mutations that cause CD36 deficiency in man Hum Genet. 108:2001;459-466.
31. Kodama T., Reddy P., Kishimoto C., Krieger M. Purification and characterization of a bovine acetyl low density lipoprotein receptor. Proc Natl Acad Sci USA. 85:1988;9238-9242.
32. Kuwasako T, Hirano K, Sakai N, et al.: Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism. Diabetes Care in press.
33. Matsumoto K., Hirano K., Nozaki S.et al. Expression of macrophage (Mphi) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-gamma, which regulates gain of Mphi-like phenotype in vitro, and its implication in atherogenesis. Arterioscler Thromb Vasc Biol. 20:2000;1027-1032.
34. Miyaoka K., Kuwasako T., Hirano K.et al. CD36 deficiency associated with insulin resistance. Lancet. 357:2001;686-687.
35. Nagy L., Tontonoz P., Alvarez J.G.et al. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR gamma. Cell. 93:1998;229-240.
36. Nakagawa T., Nozaki S., Nishida M.et al. Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol. 18:1998;1350-1357.
37. Nakagawa-Toyama Y., Yamashita S., Miyagawa J.et al. Localization of CD36 and scavenger receptor class A in human coronary arteries - a possible difference in the contribution of both receptors to plaque formation. Atherosclerosis. 156:2001;297-305.
38. Nakata A., Nakagawa Y., Nishida M.et al. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. Arterioscler Thromb Vasc Biol. 19:1999;1333-1339.
39. Nozaki S., Kashiwagi H., Yamashita S.et al. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subject. J Clin Invest. 96:1995;1859-1865.
40. Nozaki S., Tanaka T., Yamashita S.et al. CD36 mediates long-chain fatty acid transport in human myocardium. complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency Mol Cell Biochem. 192:1999;129-135.
41. Ockenhouse C.F., Magowan C., Chulay J.D. Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro. J Clin Invest. 84:1989;468-475.
42. Oquendo P., Hundt E., Lawler J., Seed B. CD36 directly mediates cytoadherence of Plasmodium faciparum parasitized erythrocytes. Cell. 58:1989;95-101.
43. Podrez E.A., Poliakov E., Shen Z.et al. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem. 277:2002;38,503-38,516.
44. Pravenec M., Landa V., Zidek V.et al. Transgenic rescue of defective CD36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet. 27:2001;156-158.
45. Ren Y., Silverstein R.L., Allen J., Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med. 181:1995;1857-1862.
46. Rigotti A., Acton S.L., Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem. 270:1995;16,221-16,224.
47. Ryeom S.W., Sparrow J.R., Silverstein R.L. CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium. J Cell Sci. 109:1996;387-395.
48. Schreck R., Baeuerle P.A. NK-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Mol Cell Biol. 10:1990;1281-1286.
49. Silverstein R.L., Asch A.S., Nachman R.L. Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest. 84:1989;546-552.
50. Silverstein R.L., Febbraio M. CD36 and atherosclerosis. Curr Opin Lipidol. 11:2000;483-491.
51. Tanaka T., Nakata T., Oka T.et al. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutation. J Lipid Res. 42:2001;751-759.
52. Tanaka T., Sohmiya K., Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol. 29:1997;121-127.
53. Tandon N.N., Lipsky R.H., Burgess W.H., Jamieson G.A. Isolation and characterization of platelet glycoprotein IV (CD36). J Biol Chem. 264:1989;7570-7575.
54. Tomiyama Y., Take H., Ikeda H.et al. Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV. Blood. 75:1990;684-687.
55. Tontonoz P., Nagy L., Alvarez J.G.et al. PPAR gamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93:1998;241-252.
56. Van Nieuwenhoven F.A., Verstijnen C.P., Abumrad N.A.et al. Putative membrane fatty acid translocase and cytoplasmic fatty acid-binding protein are co-expressed in rat heart and skeletal musles. Biochem Biophys Res Commun. 207:1995;747-752.
57. Yanai H., Chiba H., Fujiwara H.et al. Metabolic changes in human CD36 deficiency displayed by glucose loading. Thromb Haemost. 86:2001;995-999.
58. Yanai H., Chiba H., Morimoto M.et al. Human CD36 deficiency is associated with elevation in low-density lipoprotein-cholesterol. Am J Med Genet. 93:2000;299-304.
59. Yamamoto N., Ikeda H., Tandon N.N.et al. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors. Naka-platelets lack detectable GPIV (CD36) Blood. 76:1990;1698-1703.
60. 123I-BMIPP fatty acid analogue in healthy and CD36-deficient subjects. J Nucl Med. 41:2000;1134-1138.